Michael Penn is a physician-scientist turned venture investor with an MD/PhD from UCSF and nearly a decade at Genentech before moving into venture capital, giving him an unusually deep combination of clinical, scientific, commercial pharma, and investing experience. He integrates modern neuroscience with mindful awareness and ancient wisdom practices into his strategy work through Health Equity Ventures' advisory arm, an uncommon cross-disciplinary approach among venture investors. Michael Penn is a physician-scientist turned venture investor with an MD/PhD from UCSF and nearly a decade at Genentech before moving into venture capital, giving him an unusually deep combination of clinical, scientific, commercial pharma, and investing experience. He integrates modern neuroscience with mindful awareness and ancient wisdom practices into his strategy work through Health Equity Ventures' advisory arm, an uncommon cross-disciplinary approach among venture investors.